Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
2075005
Title:
VACCIN DE SALK (IPV ) ET CONTRE LA DIPHTÉRIE, LA COQUELUCHE ET LE TÉTANOS (DPT)
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
078292471
WO application number:
JP2007069509
Type:
European patent granted for BE
Status:
Deemed Void
Publication number:
2075005
WO publication number:
WO2008044611
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
28/09/2007
Grant date:
02/12/2015
EP publication date:
01/07/2009
WO publication date:
17/04/2008
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
02/12/2015
EP B1 publication date:
02/12/2015
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
28/09/2027
Applicant
1
Name:
The Research Foundation for Microbial
Diseases of Osaka University
Legal Form:
From:
02/12/2015
Address:
Osaka University
3-1 Yamadaoka
Suita City, Osaka, Japan (JP)
To:
2
Name:
Takeda Pharmaceutical Company Limited
Legal Form:
From:
02/12/2015
Address:
1-1, Doshomachi 4-chome
Chuo-ku, Osaka- shi, Osaka 541-0045, Japan (JP)